The Board proposes the promulgation of the rule to implement Ch. 2020-7 Laws of Fla (CSHB 389) concerning collaborative practice and test and treat certifications.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-31.045Test and Treat Certification: Mandatory Continuing Education

PURPOSE AND EFFECT: The Board proposes the promulgation of the rule to implement Ch. 2020-7 Laws of Fla (CSHB 389) concerning collaborative practice and test and treat certifications.

SUMMARY: The rule will be promulgated to implement Ch. 2020-7 Laws of Fla (CSHB 389) concerning collaborative practice and test and treat certifications.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Committee meetings and Board meetings, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 465.1865, 465.01895 FS.

LAW IMPLEMENTED: 465.1865, 465.01895 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Jessica Sapp, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254; [e-mail].

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B16-31.045 Test and Treat Certification: Mandatory Continuing Education.

A licensee shall not be required to complete the 3-hour continuing education related to minor, nonchronic health conditions if the initial certificate was issued less than 12 months prior to the expiration date of the license.

Rulemaking Authority 465.1895 F.S. Law Implemented 465.1895 F.S. History-New,                      .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: August 26, 2020

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: September 9, 2020